Jul 1, 1989

Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats

Journal of Gerontology
Kyoko MiyasakaK Kitani

Abstract

Differences in pancreatic responses and CCK release to intragastric administration of a synthetic protease inhibitor (camostate) were examined in young (6-mo) and old (26-mo) female rats. When rats were sacrificed 1 hour after camostate administration (100 mg/kg), plasma CCK concentration significantly increased in both age groups and was significantly higher in young rats than in the old. Acute pancreatic responses to camostate were attenuated in old rats, compared with the young. On the other hand, 5-day administration of camostate (100 mg/kg, twice a day) increased pancreatic wet weight, chymotrypsin concentration and content in pancreas in both age groups, whereas lipase content did not increase in old rats although it significantly increased in young rats. Plasma CCK concentrations were not significantly different between young and old rats. It is concluded that the acute response of CCK release to camostate is attenuated in old rats, but the capability of chronic pancreatic adaptation of chymotrypsin content to camostate is well maintained in old rats.

  • References
  • Citations10

References

  • We're still populating references for this paper, please check back later.

Mentioned in this Paper

CCK-33
Senility
Secretory Rate
Rats, Inbred F344
Guanidines
Foypan
Intubation, Nasogastric
Foy
Dose-Response Relationship, Drug
Protease Inhibitors

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

IGA Glomerulonephritis

IgA glomerulonephritis is a chronic form of glomerulonephritis characterized by deposits of predominantly Iimmunoglobin A in the mesangial area. Discover the latest research on IgA glomerulonephritis here.

Cryogenic Electron Microscopy

Cryogenic electron microscopy (Cryo-EM) allows the determination of biological macromolecules and their assemblies at a near-atomic resolution. Here is the latest research.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

LRRK2 & Immunity During Infection

Mutations in the LRRK2 gene are a risk-factor for developing Parkinson’s disease. However, LRRK2 has been shown to function as a central regulator of vesicular trafficking, infection, immunity, and inflammation. Here is the latest research on the role of this kinase on immunity during infection.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Meningococcal Myelitis

Meningococcal myelitis is characterized by inflammation and myelin damage to the meninges and spinal cord. Discover the latest research on meningococcal myelitis here.

Alzheimer's Disease: MS4A

Variants within membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease by recent genome-wide association studies. Here is the latest research.